A REVIEW ON CIPROFLOXACIN: DOSAGE FORM PERSPECTIVE
DOI:
https://doi.org/10.22159/ijap.2018v10i4.25315Keywords:
Ciprofloxacin, Drug delivery systems, Analytical methodsAbstract
Ciprofloxacin (CF) is one of the topmost selling antibiotics and it is available at a cheap cost which is used to treat many bacterial infections. Many research scientists are working on this drug for various applications on different drug delivery systems. The main objective of this paper is to enlighten about the details of pure drug CF and its delivery systems along with current research on this drug. This review focused on history, pharmacokinetics, mechanism of action, types of dosage form available in the market with their cost, current research going on this drug with their applications and methods development for estimation of CF. It also highlighted the possible interactions and adverse drug reactions of CF and patents available. The present review revealed that the only analytical method for estimation of CF was developed in the first decade, few drug delivery systems (DDS) of CF were developed in the second decade and more research work on the development of novel DDS of CF founded in the last decade.
Downloads
References
https://books.google.co.in/books. [Last accessed on 10 Jan 2018]
https://www.medicinenet.com/ciprofloxacin/article.htm. [Last accessed on 10 Jan 2018]
Mark FL, James ML, Lanc J, Robert HW, Edward EC, Margerison, et al. Ciprofloxacin and the fluoroquinolones. Am J Med 1989;87:2-8.
Pichler H, Diridl G, Wolf D. Ciprofloxacin in the treatment of acute bacterial diarrhea: a double-blind study. Eur J Clin Microbiol 1986;5:241-3.
Umadevi S, Rohini B, Nithyapriya, Sasidharan. Formulation and evaluation of ciprofloxacin dental films for periodontitis. J Chem Pharm Res 2012;4:2964-71.
Committee on Antimicrobial Agents, Canadian Infectious Disease Society, Thomas JL. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Can Med Assoc J 1994;150:669-76.
Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. Drugbank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 2006;34:668-72.
http://www.drugsupdate.com/generic/view/475/ciprofloxacin. [Last accessed on 10 Jan 2018]
Scherer R, Jessica P, Juliete F, Mariana L, Mayara L. Determination of ciprofloxacin in pharmaceutical formulations using HPLC method with UV detection. Indian J Pharm Sci 2014;76:541-4.
http://www.medindia.net/drug-price/CIPROFLOXACIN.htm. [Last accessed on 10 Jan 2018]
https://www.fda.gov/downloads/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/GenericDrugs/UCM564441.pdf. [Last accessed on 10 Jan 2018]
https://pubchem.ncbi.nlm.nih.gov/compound/ciprofloxacin. [Last accessed on 10 Jan 2018]
Madan MG, Maulesh MC, Madhulika G. Formulation development and evaluation of gastro retentive floating tablet of ciprofloxacin hydrochloride. Int J Pharm Pharm Sci 2016;8:149-52.
SB Makwana, VA Patel, SJ Parmar. Development and characterization of in-situ gel for the ophthalmic formulation containing ciprofloxacin hydrochloride. Results Pharma Sci 2016;6:1–6.
Daniel CR, Seth T, David MB, Nicole LW, Sandra CB, Luke RB, et al. Ciprofloxacin-loaded keratin hydrogels prevent pseudomonas aeruginosa infection and support healing in a porcine full-thickness excisional wound. Adv Wound Care 2014;4:457-68.
Ashwin K, Ramesh S, Ramesh, Sudhakar B, Goverdhan Reddy P. Design and evaluation of biodegradable periodontal films containing ciprofloxacin and ornidazole. Sch Acad J Pharm 2013;2:60-9.
Smriti M, Jitendra P, Sumeet D. Formulation and evaluation of floating microbeads of ciprofloxacin hcl by emulsion gelation method. Int J Pharm Life Sci 2013;4:2876-84.
Raheem SA, Hussein AH, Abbashayder K, Matrood MK, Azeez OS. Effect of method of preparation on physical properties of ciprofloxacin hcl elastic liposomes intended to be utilized in the treatment of acne vulgaris. Int J Res Ayur Pharm 2013;4:742-6.
Sathish Reddy E, Mohammed MI, Syed MK, Syed AB, Mohammed I. Formulation and evaluation of sustained release floating tablets of ciprofloxacin with hepato-protectant. Int J Pharm Appl 2012;3:289-92.
Mudgul VK, Rajat K, Saraogi GK, Singhai AK, Sharma D. Formulation and evaluation of sustained release floating tablets of ciprofloxacin. Int Res J Pharm 2012;3:120-2.
Mohamed AA, Mohamed AA, Mohamed SH. Design and evaluation of ciprofloxacin hydrochloride ocular inserts. Int J PharmTech Res 2011;3:1750-63.
Himabindu TVL, Vidyavathi M, Kavitha, Sastry TP, Suresh Kumar RV. Preparation and evaluation of ciprofloxacin loaded chitosan-gelatin composite film for wound healing activity. Int J Drug Delivery 2010;2:173-82.
Mukhopadhyay S, Goswami L, Satheesh MNV, Upadhyaya K. Formulation and evaluation of floating bioadhesive tablets of ciprofloxacin hydrochloride by direct compression technique. Int J Pharm Pharm Sci 2010;2:113-5.
Ramji AKA, Chandra Sekhara Rao G, Prabhakar Reddy V. Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets. AAPS Pharm Sci Tech 2009;10:220-6.
Mohammed GA, Harish NM, Narayana Charyulu R, Prabhakar P. Formulation of chitosan-based ciprofloxacin and diclofenac film for periodontitis therapy. Trop J Pharma Res 2009;8:33-41.
Chandra Mohan E, Jagan Mohan K, Venkatesham A. Preparation and evaluation of in-situ-gels for ocular drug delivery. J Pharm Res 2009;2:1089-94.
Srinatha A, Jayanta KP. Multi-unit floating alginate system: effect of additives on ciprofloxacin release. Drug Delivery 2008;15:471-6.
Varshosaz J, Tavakoli N, Roozbahani F. Formulation and in vitro characterization of ciprofloxacin floating and bioadhesive extended-release tablets. Drug Delivery 2006;13:277-85.
Rockade VS, Kadu PK. Formulation and evaluation of novel anti bacterial ciprofloxacin loaded niosomal cream. Int Res J Pharm 2015;6:519-27.
Weber A, Chaffin D, Smith A, Opheim KE. Quantitation of ciprofloxacin in body fluids by high-pressure liquid chromatography antimicrobial agents and chemotherapy. J Pharma Biomed Anal 1985;27:531-5.
Jehl F , Gallion C, Debs J, Brogard JM, Monteil H, Minck R. High-performance liquid chromatographic method for determination of ciprofloxacin in biological fluids. J Chromatography 1985;339:347-57.
Marika K, Kimiko T, Tsutomu K, Koichi N, Shigeyuki N. Determination of ciprofloxacin in plasma and urine by HPLC with ultraviolet detection. Clin Chem 1998;44:1251–5.
Zotou A, Miltiadou N. Sensitive LC determination of ciprofloxacin in pharmaceutical preparations and biological fluids with fluorescence detection. J Pham Biomed Anal 2002;28:559-68.
Najla MK, Anil Kumar S, Erika Rosa MKH, Maria IR, Miritello S. Quantitative determination of ciprofloxacin and norfloxacin in pharmaceutical preparations by High performance liquid chromatography. Rev Bras Cienc Farm Brazilian J Pharm Sci 2005;41:507-13.
Edith CLC, Rudy B, Magali BA, Hérida RN. A first-derivative spectrophotometric method for the determination of ciprofloxacin hydrochloride in ophthalmic solution. Physical Chem 2012;2:116-22.
Nix DE, De Vito JM, Schentag JJ. Liquid-chromatographic determination of ciprofloxacin in serum and urine. Clin Chem 1985;31:684-6.
Marika T Granfors, Janne TB, Mikko N, Pertti JN. Ciprofloxacin greatly increases concentrations and cypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2–mediated presystemic metabolism. Clin Pharmacol Ther 2004;76:598–606.
FDA package insert ciprofloxacin HCl, Bayer HealthCare Pharmaceuticals Inc. Initial U. S. Approval; 1987.
CIPRO®(CIPROFLOXACINhydrochloride)TABLETSCIPRO®(CIPROFLOXACIN*)ORAL SUSPENSION; FDA leaf let. Available from: https://aidsinfo.nih.gov/drugs/458/ciprofloxacin/69/professional. [Last accessed on 10 Jan 2018]
Janis V, Maria V, Kevin C, Liberato C, Anthony SI, Lilian MA, et al. Factors affecting penetration of CIPROFLOXACIN in lower extremity ischemic tissues. Int J Low Extrem Wounds 2016;15:126-31.
Sarveshwer Rao VV, Rambhau D, Ramesh Rao B, Srinivasu P. Antimicrobial agents and chemotherapy circadian variation in urinary excretion of ciprofloxacin after a Single-Dose Oral Administration at 1000 and 2200 H in human subjects. Antimicro Agents Chemother 1997;41:1802-4.
Tomasz K, Natalia G, Joanna O, Jakub MN, Jan A, Jakub T, et al. Ciprofloxacin is a potential topoisomerase ii inhibitor for the treatment of NSCLC. Int J Oncol 2012;41:1943-9.
Imran H, Ishtiaq AQ, Ali Awan M, Muhammad AK, Aftab T. Degradation and inactivation of ciprofloxacin by photocatalysis using Tio2 nanoparticles. J Appl Pharm 2012;1:487-97.
Gayatri DS, Gupta KC. Photo and UV degradation of ciprofloxacin Antibiotic. Int J Curr Microbiol Appl Sci 2014;3:641-8.
Abbas K, Zafar I, Muhammad IK, Jamshaid AK, Muhammad KJ, Zia A. Drug-drug interaction between ciprofloxacin and diclofenac ophthalmic drops at ocular level. Afr J Pharm Pharmacol 2011;5:2566-74.
Ron EP. Drug-drug interactions with ciprofloxacin and other fluoroquinolone. Am J Med 1989;87:76–81.
Antoine G, Frédéric S, Magali K, François J. Comparative activity of ciprofloxacin, levofloxacin and moxifloxacin against Klebsiella pneumoniae, Pseudomonas Aeruginosa and Stenotrophomonas Maltophilia assessed by minimum inhibitory concentrations and time-kill studies. J Pone 2016;11:1-10.
Danni R, Sri agung FK, Resmi M, Elin F, Dede S, Mokhamad A. Ciprofloxacin resistance among clinical isolates from acute respiratory infections patients at community health centers in tasikmalaya, Indonesia. Asian J Pharm Clin Res 2017;Special Issur:43-5.
